EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

被引：1
|
作者：
Berinstein, Jeffrey
Steiner, Calen
Regal, Randolph
Allen, John
Kinnucan, Jami
Stidham, Ryan W.
Waljee, Akbar K.
Bishu, Shrinivas
Aldrich, Leslie
Higgins, Peter
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2019年 / 25卷
关键词：
D O I：
10.1093/ibd/izy393.050
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P044
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [21] TOFACITINIB FOR HOSPITALIZED ACUTE SEVERE ULCERATIVE COLITIS - THE TRIUMPH STUDY
    Narula, Neeraj
    Peerani, Farhad
    Hansen, Tawnya
    Bessissow, Talat
    Bressler, Brian
    Arun, Arathi
    Ancheta-Schmit, Maria
    Castelli, Jane
    Marshall, John K.
    GASTROENTEROLOGY, 2024, 166 (05) : S216 - S216
  • [22] Tofacitinib for hospitalized acute severe Ulcerative Colitis - the TRIUMPH study
    Narula, N.
    Peerani, F.
    Hansen, T.
    Bessissow, T.
    Bressler, B.
    Arun, A.
    Schmit, M.
    Castelli, J. A.
    Marshall, J. K.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I155 - I155
  • [23] Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab
    Fortuny Bauza, Marta
    Canete Pizarro, Fiorella
    Calm Salvans, Anna
    Calafat Sard, Margalida
    Domenech Morral, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 11 - 12
  • [24] Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis
    Griller, Nadia
    Cohen, Lawrence
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1213 - 1213
  • [25] Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis
    Gilmore, Robert
    Hilley, Patrick
    Srinivasan, Ashish
    Choy, Matthew
    De Cruz, Peter
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (01): : 166 - 168
  • [26] High-dose Tofacitinib in Acute Severe Ulcerative Colitis: an option to avoid colectomy?
    Ausin, M. Sierra
    Cortes, I. Latras
    Alvarez, P. Suarez
    Sanz, N. Cano
    Gonzalez, T. Elosua
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1182 - i1182
  • [27] The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review
    Mpakogiannis, Konstantinos
    Fousekis, Fotios S.
    Christodoulou, Dimitrios K.
    Katsanos, Konstantinos H.
    Narula, Neeraj
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (10) : 1311 - 1317
  • [28] Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
    Hanauer, Stephen
    Panaccione, Remo
    Danese, Silvio
    Cheifetz, Adam
    Reinisch, Walter
    Higgins, Peter D. R.
    Woodworth, Deborah A.
    Zhang, Haiying
    Friedman, Gary S.
    Lawendy, Nervin
    Quirk, Daniel
    Nduaka, Chudy I.
    Su, Chinyu
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 139 - 147
  • [29] Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials
    Sandborn, William
    Sands, Bruce E.
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Danese, Silvio
    Panes, Julian
    Feagan, Brian G.
    Reinisch, Walter
    Niezychowski, Wojciech
    Friedman, Gary
    Lawendy, Nervin
    Yu, Dahong
    Woodworth, Deborah A.
    Mukherjee, Arnab
    Healey, Paul J.
    Zhang, Haiying
    Su, Chinyu
    GASTROENTEROLOGY, 2016, 150 (04) : S157 - S157
  • [30] Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Multinational, Phase 3 Clinical Trials
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Zhang, Haiying
    Woodworth, Deborah
    Marren, Amy
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - +
12345